You searched for Antibody candidate - Page 14 of 69

In Depth 24 Apr 2024

Overcoming toxicities: are IL-2 smart cytokines the next big thing?

…has two IL-2 smart cytokine candidates in the running. Its phase 1 candidate BNT151 is being developed to treat multiple solid tumors including head and neck cancer, liver cancer, and…

April 24, 2024 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 27 Jan 2025

Top 19 most-performing biotech stocks of 2024

…of MNPR-101-Lu, a novel radiopharmaceutical treating aggressive solid tumors. This is the candidate Monopar decided to prioritize after Validive’s mitigated results. This compound combines MNPR-101, a humanized monoclonal antibody that…

January 27, 2025 - 8 minutesmins - By Jules Adam

Best in Biotech 5 Dec 2024

Five biosimilar companies you should know about

…Biogen Ongoing partnership with Merck for biosimilar candidates Samsung Bioepis is advancing a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology, ophthalmology, hematology,…

December 5, 2024 - 11 minutesmins - By Willow Shah-Neville

Best in Biotech 30 Dec 2024

Six biotech companies leading the way in India

…rapid identification of selective and potent monoclonal antibodies with the potential to enhance antibody-dependent cellular cytotoxicity (ADCC) activity. Zumutor’s lead candidate, ZM008, is a first-in-class monoclonal antibody that disrupts the…

December 30, 2024 - 8 minutesmins - By Willow Shah-Neville

In Depth 24 Jul 2023

Sarcoma research: is a breakthrough in sight?

…said Davies. Collaborating with researchers at University of California, Los Angeles (UCLA), CancerVAX’s Ewing sarcoma program is making progress, having created seven monoclonal antibody candidates, out of which six have…

July 24, 2023 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 25 Jun 2024

Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024

…with a $35 million series A round. The Georgia company is focused on developing antiviral drugs particularly targeting respiratory viruses. The company’s lead candidate, vapendavir, is a broad-spectrum capsid inhibitor…

June 25, 2024 - 7 minutesmins - By Jules Adam

News and Trends 15 Sep 2017

Swiss-US Partners Reveal New Candidate for Autoimmune Disease

Numab and Intarcia have a first candidate to combine a tri-specific antibody fragment with a mini-osmotic pump delivery system to fight autoimmune disease. Numab and Intarcia partnered in 2015 to…

September 15, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 25 Feb 2025

Seven biotech spinouts to watch out for in 2025

…KRAS is the most commonly mutated member of the RAS family, according to a study by Nature. The startup’s lead candidate BBO-8520 is a direct inhibitor that targets the ‘on’…

February 25, 2025 - 9 minutesmins - By Roohi Mariam Peter

Best in Biotech 28 Nov 2024

Six antisense oligonucleotide companies shaping the future of genetic medicine

…candidate, which recently became the first-ever RNA editing candidate to be tested in clinical trials, Wave Life Sciences also has an antisense oligonucleotide candidate called WVE-003 being tested in a…

November 28, 2024 - 10 minutesmins - By Willow Shah-Neville

antibody drug conjugate adc small cancer treatment

News and Trends 23 Dec 2022

Merck and Kelun-Biotech collaborating on seven ADC cancer candidates

…seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer. “Advances in ADC technologies are yielding a new generation of candidates designed to more precisely target and deliver potent…

December 23, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 28 May 2020

MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience

…is developing vaccine candidates for a number of infectious diseases such as Lassa fever. It also has some immuno-oncology therapies in preclinical development. Themis’ most advanced candidate is a vaccine…

May 28, 2020 - 3 minutesmins - By Helen Albert

Best in Biotech 21 May 2024

Eight companies spearheading Philadelphia’s biotech industry

…primary focus is on hormone-driven cancers, including breast, ovarian, and endometrial cancers. Context’s lead product candidate, CTIM-76, is a selective Claudin 6 (CLDN6) x CD3 bispecific antibody designed to target…

May 21, 2024 - 10 minutesmins - By Jules Adam

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Overcoming toxicities: are IL-2 smart cytokines the next big thing?

Top 19 most-performing biotech stocks of 2024

Five biosimilar companies you should know about

Six biotech companies leading the way in India

Sarcoma research: is a breakthrough in sight?

Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024

Swiss-US Partners Reveal New Candidate for Autoimmune Disease

Seven biotech spinouts to watch out for in 2025

Six antisense oligonucleotide companies shaping the future of genetic medicine

Merck and Kelun-Biotech collaborating on seven ADC cancer candidates

MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience

Eight companies spearheading Philadelphia’s biotech industry

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!